Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients T Colasanti, D Sabatinelli, C Mancone, A Giorgi, A Pecani, FR Spinelli, ... Journal of Autoimmunity 113, 102470, 2020 | 27 | 2020 |
Maladaptive autophagy in the pathogenesis of autoimmune epithelitis in Sjögren's syndrome S Colafrancesco, C Barbati, R Priori, E Putro, F Giardina, A Gattamelata, ... Arthritis & Rheumatology 74 (4), 654-664, 2022 | 22 | 2022 |
Autophagy in rheumatic diseases: role in the pathogenesis and therapeutic approaches AI Celia, S Colafrancesco, C Barbati, C Alessandri, F Conti Cells 11 (8), 1359, 2022 | 15 | 2022 |
Autophagy modulation in lymphocytes from COVID-19 patients: new therapeutic target in SARS-COV-2 infection M Vomero, C Barbati, T Colasanti, AI Celia, M Speziali, FM Ucci, ... Frontiers in Pharmacology 11, 569849, 2020 | 14 | 2020 |
Tofacitinib decreases autophagy of fibroblast-like synoviocytes from rheumatoid arthritis patients M Vomero, M Caliste, C Barbati, M Speziali, AI Celia, F Ucci, ... Frontiers in Pharmacology 13, 852802, 2022 | 11 | 2022 |
Comprehensive disease control in systemic lupus erythematosus F Ceccarelli, G Olivieri, A Sortino, L Dominici, F Arefayne, AI Celia, ... Seminars in Arthritis and Rheumatism 51 (2), 404-408, 2021 | 10 | 2021 |
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA. hy926 endothelial cell line C Barbati, T Colasanti, M Vomero, F Ceccarelli, AI Celia, C Perricone, ... Clin. Exp. Rheumatol 39, 606-611, 2021 | 8 | 2021 |
Autophagy hijacking in PBMC from COVID-19 patients results in lymphopenia C Barbati, AI Celia, T Colasanti, M Vomero, M Speziali, E Putro, ... Frontiers in Immunology 13, 903498, 2022 | 5 | 2022 |
Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus E Gomez-Bañuelos, MJ Wahadat, J Li, M Paz, B Antiochos, AI Celia, ... JCI insight 7 (19), 2022 | 4 | 2022 |
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome C Barbati, L Stefanini, T Colasanti, E Cipriano, A Celia, G Gabriele, ... Arthritis Research & Therapy 21, 1-5, 2019 | 4 | 2019 |
Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis FM Ucci, S Recalchi, C Barbati, V Manganelli, A Capozzi, G Riitano, ... Rheumatology 62 (6), 2312-2319, 2023 | 3 | 2023 |
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis A Fava, J Buyon, L Magder, J Hodgin, A Rosenberg, DS Demeke, DA Rao, ... JCI insight 9 (2), 2024 | 2 | 2024 |
Ab0145 the inhibition of Jak pathway was associated with reduction of autophagy in synoviocytes from rheumatoid arthritis patients M Vomero, M Caliste, C Barbati, T Colasanti, F Spinelli, F Ceccarelli, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1530-1531, 2019 | 2 | 2019 |
POS0297 PROTEOMIC ANALYSIS OF HISTOLOGICAL LESIONS LUPUS NEPHRITIS IDENTIFIES AN INFLAMMATORY SIGNATURE OF FIBROUS CRESCENTS AI Celia, J Hodgin, D Demeke, A Rosenberg, L Magder, J Buyon, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 390-391, 2023 | 1 | 2023 |
A new T2 lesion in a patient with the clinically isolated syndrome does not necessarily imply a conversion to multiple sclerosis F Capone, M Puthenparampil, CA Mallio, AI Celia, L Florio, P Gallo, ... Clinical Neurology and Neurosurgery 164, 138-141, 2018 | 1 | 2018 |
Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study S Colafrancesco, AI Celia, C Baldini, L Quartuccio, E Bartoloni, F Carubbi, ... Clinical and Experimental Rheumatology 41 (12), 2389-2396, 2023 | | 2023 |
LP-098 Proteomic analysis of histological lesions in lupus nephritis identifies an inflammatory signature of fibrous crescents AI Celia, J Hodgin, D Demeke, A Rosenberg, LS Magder, J Buyon, ... Lupus Science & Medicine 10 (Suppl 1), 2023 | | 2023 |
LP-097 Degranulating PR3+ myeloid cells characterize proliferative lupus nephritis AI Celia, X Yang, M Petri, A Rosenberg, A Fava Lupus Science & Medicine 10 (Suppl 1), 2023 | | 2023 |
LO-006 Change in urinary biomarkers at three months predicts 1-year treatment response of lupus nephritis better than proteinuria A Fava, J Buyon, L Magder, J Hodgin, A Rosenberg, D Demeke, D Rao, ... Lupus Science & Medicine 10 (Suppl 1), 2023 | | 2023 |
POS0288 DEGRANULATING PR3+ MYELOID CELLS CHARACTERIZE PROLIFERATIVE LUPUS NEPHRITIS AI Celia, X Yang, MA Petri, A Rosenberg, A Fava Annals of the Rheumatic Diseases 82 (Suppl 1), 385-386, 2023 | | 2023 |